Calysta

formerly Calysta Energy

Calysta is a biotech company in Menlo Park, United States, founded in 2012. It has raised $119.0M across 5 rounds, most recently a $39.0M Extension Round in September 2021.

Protein Without Limits

Employees
51–200
Founded
2012
Business Model
B2B
Total Funding
$119.0M
Last Round
$39.0M Extension RoundSep 2021
Rounds
5

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 5 funding rounds and 3 investors for this company. The full record is or through the API.

About

Calysta is a world leader in cellular agriculture, using a patented gas-fermentation platform that converts methane into single-cell protein without arable land, plant, or animal inputs. Its FeedKind, FeedKind Pet, FeedKind Net Zero, and Positive Protein ingredient lines serve aquaculture, livestock, and pet-food markets, and the company operates its first commercial FeedKind production plant in China through joint venture Calysseo, producing thousands of tonnes of protein annually to help meet growing global demand for sustainable, land-free protein.

Summary

It lists 51–200 employees. It has raised $119.0M in total across 5 rounds, most recently a $39.0M Extension Round in Sep 2021. Investors include BP Ventures, Aqua Spark and Western Technology Investment.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Extension RoundSeries D-1 ExpansionSep 2021
$39.0M

Sign up to see all 5 events

Funding: Series A through Extension Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Impossible Foods

Food technology company creating plant-based meat and dairy products that replicate the taste and...

Redwood City, United States501–1000Agtech, Biotech
Series G+Total funding$1.9BNov 2021
Apeel Sciences

Apeel Sciences develops plant-based edible coatings that extend the shelf life of fresh produce, ...

GOLETA, United States201–500Agtech, Biotech
Series FTotal funding$912.9MJul 2025
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Calysta on Indexed.vc
<a href="https://indexed.vc/companies/calysta"><img src="https://indexed.vc/api/badge/company/calysta" alt="Calysta on Indexed.vc" width="260" height="76" /></a>